Atria Wealth Solutions Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 56.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,071 shares of the healthcare conglomerate's stock after selling 18,304 shares during the period. Atria Wealth Solutions Inc.'s holdings in UnitedHealth Group were worth $4,385,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the stock. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of UnitedHealth Group by 7.4% during the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate's stock valued at $8,295,000 after buying an additional 1,089 shares in the last quarter. Sound Income Strategies LLC boosted its holdings in shares of UnitedHealth Group by 15.9% during the 1st quarter. Sound Income Strategies LLC now owns 2,399 shares of the healthcare conglomerate's stock valued at $1,257,000 after buying an additional 330 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its holdings in shares of UnitedHealth Group by 49.0% during the 1st quarter. Exchange Traded Concepts LLC now owns 2,827 shares of the healthcare conglomerate's stock valued at $1,481,000 after buying an additional 930 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently issued reports on UNH. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Truist Financial lifted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday, September 9th. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research report on Thursday, October 9th. Finally, UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of "Hold" and an average price target of $383.09.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $358.80 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business has a 50-day simple moving average of $320.57 and a two-hundred day simple moving average of $346.99. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $324.96 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.